E. Korb et al. «Excess Translation
of Epigenetic Regulators Contributes to Fragile X Syndrome and Is Alleviated by Bd4 Inhibition,» Cell 170 (September 7, 2017): 1209 - 1223.
We apply advanced reverse genetic strategies, some of which were developed by us, to analyze select classes
of epigenetic regulators in both organisms.
«Through this assessment
of epigenetic regulators, we identified PRMT1 as a top scoring «hit» in these patient - derived tumors,» said Virginia Giuliani, Ph.D., senior research scientist, IACS.
One of these, a novel inhibitor
of the epigenetic regulator KDM4, co-developed in the lab of Prof. Schüle, showed promising results.
Now, they have discovered that an inhibitor
of the epigenetic regulator KDM4 shows great promise in modulating breast cancer stem cell pathology.
Not exact matches
Durect, Corp., a biopharmaceutical company developing therapeutics based on its
epigenetic regulator program and proprietary drug delivery platforms, posted an all - time low
of 61 cents in November 2012 before embarking on an uptrend that topped out at $ 3.42 in June 2015.
The field
of cancer
epigenetics was recently transformed by the finding that genes encoding for
epigenetic regulators are among the most commonly mutated genes in human cancers.
Scientists from the cluster
of excellence BIOSS Centre for Biological Signalling Studies at the University
of Freiburg and the Freiburg University Medical Center have shown that inhibiting the
epigenetic regulator KDM4 might offer a potential novel treatment option for breast cancer patients.
His team's previous work had hinted that FMRP controls a group
of proteins called
epigenetic regulators.
«Multiple
epigenetic regulators participate in the drug - desensitizing pathway, so they could serve as new targets to improve therapy for this type
of cancer.»
Identified additional novel
epigenetic and transcriptional
regulators of cardiac hypertrophy and heart failure pathogenesis
Discovered that BET bromodomain
epigenetic regulators function as critical drivers
of heart failure pathogenesis and vascular injury responses that can be pharmacologically targeted in vivo
The fact that she has found them to be differentially regulated in angiosarcoma tumors has led to the hypothesis that there are
epigenetic regulators of these genes that have yet to be identified through the genomic profiling applied to these studies thus far.
This activation is achieved by proteins called
epigenetic regulators, which work to make specific regions
of our genome more or less accessible to transcription.
I graduated with my thesis on «
Epigenetic regulators in normal and malignant development
of skin» while working with Prof.Dr.Karin Scharffetter - Kochanek.
Tet2 is a type
of cellular enzyme known as an
epigenetic regulator — responsible for making specific chemical annotations to regions
of DNA that alter the activity
of many different genes.
She explains, «We think that HDAC2 serves as a master
regulator of memory gene expression, and during Alzheimer's disease it's elevated so it causes an
epigenetic blockade if the expression
of those memory genes.»
Many other molecules are also involved in this process, including
epigenetic regulators that help to densely pack the genome into the nucleus
of a cell, or locally unpack it to allow gene expression.
The researchers say they've found evidence that obesity changes the microRNA (miRNA) signature —
epigenetic regulators of gene expression — in both the dad's sperm and the daughter's breast tissue, suggesting that miRNAs may carry the
epigenetic information from obese dads to their daughters.
Michelle Barton, Ph.D., was nominated and elected by her scientific peers in recognition for her contributions to understanding the function
of the tumor suppressor, p53 in stem cells, particularly with respect to the discovery
of TRIM24, an E3 - ligase and
epigenetic regulator that is overexpressed in many cancers.
The discovery
of small molecule
regulators (activators or inhibitors)
of epigenetic modification enzymes provides researchers with pharmacological tools with which to investigate the biological consequences
of chromatin modifications.
Interestingly, the most commonly mutated set
of genes were those involved in
epigenetic modification (25 %
of tumors) followed by transcriptional
regulators and MAP kinase - associated genes (12 - 15 %).
We applied our technology to several
epigenetic regulators, recovering bi-allelic targeted clones with a high efficiency
of 60 % and used Flp recombinase to restore expression in two null cell lines to demonstrate how our system confirms causality through mutant phenotype reversion.
Next up was Didier Trono who talked about how transposable elements and their
epigenetic control mechanisms are key
regulators of transcriptional networks in PSCs.